Mitochondrial DNA and cancer

Marmara Medical Journal

Volumn 20, Issue 2, 2007, Pages 127-136

  Aral, Cenk ^a   Özer, Ayşe ^a  

^a Anesteziyoloji ve Reanimasyon A D   (Turkey)

Author keywords

Apoptosis; Genomic instability; Mitochondrial DNA; Mutation; Solid tumors

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BREAST CANCER; CANCER GENETICS; CARCINOGENESIS; COLORECTAL CANCER; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; MITOCHONDRIAL GENE; MUTATION; REVIEW; SOLID TUMOR; STOMACH CANCER; THYROID CANCER;

EID: 43449084655     PISSN: 10191941     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Scheffler IE, Mitochondria, Wiley-Liss Publication, NY, 1999.
2. Anderson S, Bankier AT, Barrel BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
3. MITOMAP: A human mitochondrial genome database. http://www.mitomap.org, 2006.
4. Kanki T, Nakayama H, Sasaki N, et al. Mitochondrial nucleoid and transcription factor A. Ann NY Acad Sci 2004; 1011: 61-68.
5. Larsen NB, Ramussen M, Ramussen LJ. Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 2005; 5: 89-108.
6. DiMauro S. Mitochondrial diseases. Biochem Biophys Acta 2004; 1658: 80-88.
7. Bohr VA. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002; 32: 804-812.
8. Ide H, Kow YW, Wallace SS. Thymine glycols and urea residues in M13 DNA constitute replicative blocks in vitro. Nucleic Acids Res 1985; 13: 8035-8052.
9. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 1993; 9: 246-249.
10. Pinz KG, Shibutani S, Bogenhagen DF. Action of mitochondrial DNA polymerase at sites of base loss or oxidative damage. J Biol Chem 1995; 270: 9202-9206.
11. Loft S, Moller P. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid Redox Signal 2006; 8: 1021-1031.
12. Reid R. Can migratory mitochondrial DNA activate oncogenes. Trends Biochem 1983; 8: 190-191.
13. Richard SM, Bailliet G, Paez GL, et al. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 2000; 60: 4231-4237.
14. Levin DE, Yamasaki E, Ames BN. A new Salmonella tester strain, TA97, for the detection of frameshift mutagens: a run of cytosines as a mutational hot-spot. Mutat Res 1982; 94: 315-330.
15. Owen JE, Schultz DW, Taylor A, Smith GR. Nucleotide sequence of the lysozyme gene of bacteriophage T4: analysis of mutations involving repeated sequences. J Mol Biol 1983; 165: 229-248.
16. Levinson G, Gutman GA. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol 1987; 4: 203-221.
17. Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998; 20: 291-293.
18. Habano W, Nakamura SI, Sugai T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene 1998; 17: 1931-1937.
19. Habano W, Sugai T, Yoshida T, Nakamura SI. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 1999; 83: 625-629.
20. Bianchi MS, Bianchi NO, Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 1995; 71: 99-103.
21. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older individuals. Nuc Acids Res 1990; 18: 6927-6933.
22. Livneh Z. Directed mutagenesis method for analysis of mutagen specificity: application to ultraviolet-induced mutagenesis. Proc Natl Acad Sci USA 1983; 80: 237-241.
23. Flanagan JG, Lefranc MP, Rabbitts TH. Mechanisms of divergence and convergence of the human immunoglobulin α-1 and α-2 constant region gene sequences. Cell 1984; 36: 681-688.
24. Kunkel TA. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis: production of frameshift, base substitution, and deletion mutations. J Biol Chem 1985; 260: 5787-5796.
25. Burgart LJ, Zheng J, Shu Q, et al. Somatic mitochondrial mutation in gastric cancer. Am J Pathol 1995; 147: 1105-1111.
26. De la Chapelle A, Peltomaki P. The genetics of hereditary common cancers. Curr Opin Genet Dev 1998; 8: 298-303.
27. Peltomaki P. DNA mismatch repair and cancer. Rev Mutat Res 2001; 488: 77-85.
28. Clayton DA. Replication of animal mitochondrial DNA. Cell 1982; 28: 693-705.
29. Kunkel TA, Alexander PS. The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J Biol Chem 1986; 261: 160-166.
30. Pinz KG, Shibutani S, Bogenhagen DF. Action of mitochondrial DNA polymerase γ at sites of base loss or oxidative damage. J Biol Chem 1995; 270: 9202-9206.
31. Faraj A, Fowler DA, Bridges EG, Sommadossi JP. Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob Agents Chemother 1994; 38: 924-930.
32. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med 1995; 1: 417-422.
33. Ropp PA, Copeland WC. Cloning and characterization of the human mitochondrial DNA polymerase γ. Genomics 1996; 36: 449-458.
34. Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-311.
35. Lee MS, Kim JA, Park SY. Resistance of ro cells against apoptosis. Ann NY Acad Sci 2004; 1011: 146-153.
36. Liu CY, Lee CF, Hong CH, Wei YH. Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis. Ann NY Acad Sci 2004; 1011: 133-145.
37. Shidara Y, Yamagata K, Kanamori T, et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005; 65: 1655-1663.
38. Schoeler S, Szibor R, Gellerich FN, et al. Mitochondrial DNA deletions sensitize cell to apoptosis at low heteroplasmy levels. Biochem Biophys Res Commun 2005; 332: 43-49.
39. Mott JL, Zhang D, Stevens M, et al. Oxidative stress is not an obligate mediator of disease provoked by mitochondrial DNA mutations. Mutat Res 2001; 474: 35-45.
40. Park SY, Chang I, Kim JY, et al. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J Biol Chem 2004; 279: 7512-7520.
41. Jacques C, Chevrollier A, Loiseau D, et al. mtDNA controls expression of the death associated protein 3. Exp Cell Res 2006; 312: 737-745.
42. Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 2000; 19: 2060-2066.
43. Maximo V, Soares P, Lima J, et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurtle cell tumors. Am J Pathol 2002; 160: 1857-1865.
44. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, et al. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res 2002; 62: 7031-7041.
45. Tong BC, Ha PK, Dhir K, et al. Mitochondrial DNA alteations in thyroid cancer. J Surg Oncol 2003; 82: 170-173.
46. Lohrer HD, Hieber L, Zitzelsberger H. Differential mutation frequency in mitochondrial DNA from thyroid tumors. Carcinogenesis 2002; 23: 1577-1582.
47. Maximo V, Lima J, Soares P, et al. Mitochondrial D-loop instability in thyroid tumors is not a marker of malignancy. Mitochondrion 2005; 5: 333-340.
48. Aikhionbare FO, Khan M, Carey D, et al. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer 2004; 3:30.
49. Nishikawa M, Oshitani N, Matsumoto T, et al. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br J Cancer 2005; 93: 331-337.
50. Greaves LC, Preston SL, Tadrous PJ, et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci 2006; 103: 714-719.
51. Lee HC, Yin PH, Lin JC, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann NY Acad Sci 2005; 1042: 109-122.
52. Kose K, Hiyama T, Tanaka S, et al. Somatic mutations of mitochondrial DNA in digestive tract cancers. J Gastroenterol Hepatology 2005; 20: 1679-1684.
53. Lievre A, Chapusot C, Bouvier AM, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 2005; 23: 3517-3525.
54. Aral C, Kaya H, Ataizi-Çelikel Ç, et al. A novel approach for rapid screening of mitochondrial D310 polymorphism. BMC Cancer 2006; 6:21.
55. Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 2002; 62: 972-976.
56. Parrella P, Xiao Y, Fliss M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 2001; 61: 7623-7626.
57. Parrella P, Seripa D, Matera MG, et al. Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors cytological specimens. Cancer Lett 2003; 190: 73-77.
58. Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients. Breast Cancer Res Treat 2004; 84: 99-105.
59. Zhu W, Qin W, Sauter ER. Large-scale mitochondrial mutations and nuclear genome instability in human breast cancer. Cancer Detect Prevent 2004; 28: 119-126.
60. Dani MAC, Dani SU, Lima SPG, et al. Less ΔmtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 2004; 3: 395-409.
61. Tamura G, Nishizuka S, Maesawa C, et al. Mutations in mitochondrial control region DNA in gastric tumors of Japanese patients. Eur J Cancer 1999; 35: 316-319.
62. Maximo V, Soares P, Seruca R, Sobrinho-Simoes M. Comments on: Mutations in mitochondrial control region DNA in gastric tumors of Japanese patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319. Eur J Cancer 1999; 35: 1407-1408.
63. Han CB, Li F, Zhao YJ, Ma JM, et al. Variations of mitochondrial D-loop region plus downstream gene 12S rRNA-tRNAphe and gastric carcinomas. World J Gastroenterol 2003; 9: 1925-1929.
64. Zhao YB, Yang HY, Zhang XW, Chen GY. Mutation in D-loop region of mitochondrial DNA in gastric cancer and significance. World J Gastroenterol 2005; 11: 3304-3306.
65. Wu CW, Yin PH, Hung WY, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 2005; 44:19-28.
66. Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer 2002; 1: 9.
67. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 2001; 488: 119-133.